Multiplex testing platform to simultaneously detect and identify plasmodium species infections for diagnostics and as epidemiological surveillance tool
Active Cooperative Agreement Awarded Last action
- Award ID
- HT94252420003
- Recipient
-
The Geneva Foundation UEI TR9RX33188T4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,857,470
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 61% complete
- Place of performance
- Tacoma, WA 98402, USA
Award details come from USAspending.gov.
About this award
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale Diagnostics LLC will contribute its expertise in assay development and biomarker detection to support this research initiative. The federal grant funding enables innovative biomedical research to improve health outcomes for military service members and the broader public.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $1,857,470 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Meso Scale Diagnostics LLC | $667,042 | |
| Meso Scale Diagnostics LLC | $374,664 |
Quick answers
Who received award HT94252420003?
HT94252420003 was awarded to The Geneva Foundation by Defense Health Agency (Department of Defense) on June 1, 2024.
How much is award HT94252420003 worth?
$1,857,470 has been obligated on HT94252420003.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award